<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37752364</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Cellular and molecular life sciences : CMLS</Title><ISOAbbreviation>Cell Mol Life Sci</ISOAbbreviation></Journal><ArticleTitle>Selective removal of misfolded SOD1 delays disease onset in a mouse model of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>304</StartPage><MedlinePgn>304</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00018-023-04956-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease. There is no cure currently. The discovery that mutations in the gene SOD1 are a cause of ALS marks a breakthrough in the search for effective treatments for ALS. SOD1 is an antioxidant that is highly expressed in motor neurons. Human SOD1 is prone to aberrant modifications. Familial ALS-linked SOD1 variants are particularly susceptible to aberrant modifications. Once modified, SOD1 undergoes conformational changes and becomes misfolded. This study aims to determine the effect of selective removal of misfolded SOD1 on the pathogenesis of ALS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Based on the chaperone-mediated protein degradation pathway, we designed a fusion peptide named CT4 and tested its efficiency in knocking down intracellularly misfolded SOD1 and its efficacy in modifying the pathogenesis of ALS.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Expression of the plasmid carrying the CT4 sequence in human HEK cells resulted in robust removal of misfolded SOD1 induced by serum deprivation. Co-transfection of the CT4 and the G93A-hSOD1 plasmids at various ratios demonstrated a dose-dependent knockdown efficiency on G93A-hSOD1, which could be further increased when misfolding of SOD1 was enhanced by serum deprivation. Application of the full-length CT4 peptide to primary cultures of neurons expressing the G93A variant of human SOD1 revealed a time course of the degradation of misfolded SOD1; misfolded SOD1 started to decrease by 2 h after the application of CT4 and disappeared by 7 h. Intravenous administration of the CT4 peptide at 10&#xa0;mg/kg to the G93A-hSOD1 reduced human SOD1 in spinal cord tissue by 68% in 24 h and 54% in 48 h in presymptomatic ALS mice. Intraperitoneal administration of the CT4 peptide starting from 60&#xa0;days of age significantly delayed the onset of ALS and prolonged the lifespan of the G93A-hSOD1 mice.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The CT4 peptide directs the degradation of misfolded SOD1 in high efficiency and specificity. Selective removal of misfolded SOD1 significantly delays the onset of ALS, demonstrating that misfolded SOD1 is the toxic form of SOD1 that causes motor neuron death. The study proves that selective removal of misfolded SOD1 is a promising treatment for ALS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Guan</LastName><ForeName>Teng</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Xiaosha</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Forensic Medicine, Hebei North University, Zhangjiakou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Chaoxian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, Southwest Medical University, Luzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiasi Vicky</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yongquan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzban</LastName><ForeName>Hassan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yu Tian</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Brain Research Centre and Department of Medicine, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Jiming</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2859-9831</Identifier><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada. Jiming.Kong@umanitoba.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Max Rady College of Medicine, University of Manitoba, 745 Bannatyne Avenue, Winnipeg, MB, R3E 0J9, Canada. Jiming.Kong@umanitoba.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cell Mol Life Sci</MedlineTA><NlmUniqueID>9705402</NlmUniqueID><ISSNLinking>1420-682X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Chaperone-mediated autophagy</Keyword><Keyword MajorTopicYN="N">Lysosome</Keyword><Keyword MajorTopicYN="N">Misfolded SOD1</Keyword><Keyword MajorTopicYN="N">Protein degradation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>26</Day><Hour>23</Hour><Minute>39</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37752364</ArticleId><ArticleId IdType="doi">10.1007/s00018-023-04956-9</ArticleId><ArticleId IdType="pii">10.1007/s00018-023-04956-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal-Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264(5166):1772&#x2013;1775</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId><ArticleId IdType="doi">10.1126/science.8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14(6):1105&#x2013;1116</Citation><ArticleIdList><ArticleId IdType="pubmed">7605627</ArticleId><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien J-P (2001) Amyotrophic lateral sclerosis: unfold the toxicity of the misfolded. Cell 104:581&#x2013;591</Citation><ArticleIdList><ArticleId IdType="pubmed">11239414</ArticleId><ArticleId IdType="doi">10.1016/S0092-8674(01)00244-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, Goolsby H, Fontaine BA, Lemay N, McKenna-Yasek D et al (2010) Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 13(11):1396&#x2013;1403</Citation><ArticleIdList><ArticleId IdType="pubmed">20953194</ArticleId><ArticleId IdType="pmc">2967729</ArticleId><ArticleId IdType="doi">10.1038/nn.2660</ArticleId></ArticleIdList></Reference><Reference><Citation>Guareschi S, Cova E, Cereda C, Ceroni M, Donetti E, Bosco DA, Trotti D, Pasinelli P (2012) An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc Natl Acad Sci USA 109(13):5074&#x2013;5079</Citation><ArticleIdList><ArticleId IdType="pubmed">22416121</ArticleId><ArticleId IdType="pmc">3324021</ArticleId><ArticleId IdType="doi">10.1073/pnas.1115402109</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzi SA, Urushitani M, Julien JP (2007) Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem 102(1):170&#x2013;178</Citation><ArticleIdList><ArticleId IdType="pubmed">17394546</ArticleId><ArticleId IdType="doi">10.1111/j.1471-4159.2007.04531.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X, Jin WY, Lu J, Wang J, Wang YT (2014) Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation. Nat Neurosci 17(3):471&#x2013;480</Citation><ArticleIdList><ArticleId IdType="pubmed">24464042</ArticleId><ArticleId IdType="pmc">3937121</ArticleId><ArticleId IdType="doi">10.1038/nn.3637</ArticleId></ArticleIdList></Reference><Reference><Citation>Dice JF, Terlecky SR, Chiang HL, Olson TS, Isenman LD, Short-Russell SR, Freundlieb S, Terlecky LJ (1990) A selective pathway for degradation of cytosolic proteins by lysosomes. Semin Cell Biol 1(6):449&#x2013;455</Citation><ArticleIdList><ArticleId IdType="pubmed">2103896</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, Fukutomi H, Noguchi T, Matsuzawa A, Takeda K, Ichijo H (2008) ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev 22(11):1451&#x2013;1464</Citation><ArticleIdList><ArticleId IdType="pubmed">18519638</ArticleId><ArticleId IdType="pmc">2418582</ArticleId><ArticleId IdType="doi">10.1101/gad.1640108</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Zhang X, Li C, Guan T, Shang H, Cui L, Li XM, Kong J (2013) S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis. J Neurochem 124(1):45&#x2013;58</Citation><ArticleIdList><ArticleId IdType="pubmed">23043510</ArticleId><ArticleId IdType="doi">10.1111/jnc.12046</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu S, Campbell HM, Dittel BN, Ray A (2010) Purification of specific cell population by fluorescence activated cell sorting (FACS). J Vis Exp. 10(41):1546</Citation></Reference><Reference><Citation>Li W, Guan T, Zhang X, Wang Z, Wang M, Zhong W, Feng H, Xing M, Kong J (2015) The effect of layer-by-layer assembly coating on the proliferation and differentiation of neural stem cells. ACS Appl Mater Interfaces 7(5):3018&#x2013;3029</Citation><ArticleIdList><ArticleId IdType="pubmed">25347385</ArticleId><ArticleId IdType="doi">10.1021/am504456t</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson CE, McCulloch M, Sorenson A, Barnett SC, Seed BV, Griffiths IR, McLaughlin M (2008) Myelinated, synapsing cultures of murine spinal cord&#x2014;validation as an in vitro model of the central nervous system. Eur J Neurosci 28(8):1518&#x2013;1535</Citation><ArticleIdList><ArticleId IdType="pubmed">18793322</ArticleId><ArticleId IdType="pmc">2777255</ArticleId><ArticleId IdType="doi">10.1111/j.1460-9568.2008.06415.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Borchelt DR (2008) A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J Biol Chem 283(20):13528&#x2013;13537</Citation><ArticleIdList><ArticleId IdType="pubmed">18316367</ArticleId><ArticleId IdType="pmc">2376231</ArticleId><ArticleId IdType="doi">10.1074/jbc.M800564200</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, Copeland NG, Jenkins NA, Borchelt DR (2003) Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet 12(21):2753&#x2013;2764</Citation><ArticleIdList><ArticleId IdType="pubmed">12966034</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddg312</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarze SRHA, Vocero-Akbani A, Dowdy SF (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285(5433):1569&#x2013;1572</Citation><ArticleIdList><ArticleId IdType="pubmed">10477521</ArticleId><ArticleId IdType="doi">10.1126/science.285.5433.1569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Y, Shibata Y, Yun C, Ron D, Rapoport TA (2004) A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429(6994):841&#x2013;847</Citation><ArticleIdList><ArticleId IdType="pubmed">15215856</ArticleId><ArticleId IdType="doi">10.1038/nature02656</ArticleId></ArticleIdList></Reference><Reference><Citation>Lilley BN, Ploegh HL (2004) A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429(6994):834&#x2013;840</Citation><ArticleIdList><ArticleId IdType="pubmed">15215855</ArticleId><ArticleId IdType="doi">10.1038/nature02592</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujisawa T, Homma K, Yamaguchi N, Kadowaki H, Tsuburaya N, Naguro I, Matsuzawa A, Takeda K, Takahashi Y, Goto J et al (2012) A novel monoclonal antibody reveals a conformational alteration shared by amyotrophic lateral sclerosis-linked SOD1 mutants. Ann Neurol 72(5):739&#x2013;749</Citation><ArticleIdList><ArticleId IdType="pubmed">23280792</ArticleId><ArticleId IdType="doi">10.1002/ana.23668</ArticleId></ArticleIdList></Reference><Reference><Citation>Homma K, Fujisawa T, Tsuburaya N, Yamaguchi N, Kadowaki H, Takeda K, Nishitoh H, Matsuzawa A, Naguro I, Ichijo H (2013) SOD1 as a molecular switch for initiating the homeostatic ER stress response under zinc deficiency. Mol Cell 52(1):75&#x2013;86</Citation><ArticleIdList><ArticleId IdType="pubmed">24076220</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2013.08.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Shang H, Qiu X, Fujiwara N, Cui L, Li XM, Gao TM, Kong J (2012) Oxidative modification of cysteine 111 promotes disulfide bond-independent aggregation of SOD1. Neurochem Res 37(4):835&#x2013;845</Citation><ArticleIdList><ArticleId IdType="pubmed">22219129</ArticleId><ArticleId IdType="doi">10.1007/s11064-011-0679-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaj T, Ojala DS, Ekman FK, Byrne LC, Limsirichai P, Schaffer DV (2017) In vivo genome editing improves motor function and extends survival in a mouse model of ALS. Sci Adv 3(12):eaar3952</Citation><ArticleIdList><ArticleId IdType="pubmed">29279867</ArticleId><ArticleId IdType="pmc">5738228</ArticleId><ArticleId IdType="doi">10.1126/sciadv.aar3952</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim CKW, Gapinske M, Brooks AK, Woods WS, Powell JE, Zeballos CM, Winter J, Perez-Pinera P, Gaj T (2020) Treatment of a mouse model of ALS by in vivo base editing. Mol Ther 28(4):1177&#x2013;1189</Citation><ArticleIdList><ArticleId IdType="pubmed">31991108</ArticleId><ArticleId IdType="pmc">7132599</ArticleId><ArticleId IdType="doi">10.1016/j.ymthe.2020.01.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Foust KD, Salazar DL, Likhite S, Ferraiuolo L, Ditsworth D, Ilieva H, Meyer K, Schmelzer L, Braun L, Cleveland DW et al (2013) Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Mol Ther 21(12):2148&#x2013;2159</Citation><ArticleIdList><ArticleId IdType="pubmed">24008656</ArticleId><ArticleId IdType="pmc">3863799</ArticleId><ArticleId IdType="doi">10.1038/mt.2013.211</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A, Cole T, Wegener AJ, Tomassy GS, Setnicka A, Farley BJ, Schoch KM, Hoye ML, Shabsovich M, Sun L et al (2018) Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Investig 128(8):3558&#x2013;3567</Citation><ArticleIdList><ArticleId IdType="pubmed">30010620</ArticleId><ArticleId IdType="pmc">6063493</ArticleId><ArticleId IdType="doi">10.1172/JCI99081</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, Genge A, Glass J, Ladha S, Ludolph AL et al (2020) Phase 1&#x2013;2 trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med 383(2):109&#x2013;119</Citation><ArticleIdList><ArticleId IdType="pubmed">32640130</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C, Berry JD, McKenna-Yasek DM, Gernoux G, Owegi MA, Pothier LM, Douthwright CL, Gelevski D, Luppino SD, Blackwood M et al (2020) SOD1 suppression with adeno-associated virus and microRNA in familial ALS. N Engl J Med 383(2):151&#x2013;158</Citation><ArticleIdList><ArticleId IdType="pubmed">32640133</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2005056</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding H, Schwarz DS, Keene A, Affar EB, Fenton L, Xia X, Shi Y, Zamore PD, Xu Z (2003) Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2(4):209&#x2013;217</Citation><ArticleIdList><ArticleId IdType="pubmed">12934714</ArticleId><ArticleId IdType="doi">10.1046/j.1474-9728.2003.00054.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Raoul C, Abbas-Terki T, Bensadoun JC, Guillot S, Haase G, Szulc J, Henderson CE, Aebischer P (2005) Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 11(4):423&#x2013;428</Citation><ArticleIdList><ArticleId IdType="pubmed">15768028</ArticleId><ArticleId IdType="doi">10.1038/nm1207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo-Hernandez M, Tadokoro T, Navarro MR, Platoshyn O, Kobayashi Y, Marsala S, Miyanohara A, Juhas S, Juhasova J, Skalnikova H et al (2020) Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS. Nat Med 26(1):118&#x2013;130</Citation><ArticleIdList><ArticleId IdType="pubmed">31873312</ArticleId><ArticleId IdType="doi">10.1038/s41591-019-0674-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell JE, Lim CKW, Krishnan R, McCallister TX, Saporito-Magrina C, Zeballos MA, McPheron GD, Gaj T (2022) Targeted gene silencing in the nervous system with CRISPR&#x2013;Cas13. Sci Adv 8(3):eabk2485</Citation><ArticleIdList><ArticleId IdType="pubmed">35044815</ArticleId><ArticleId IdType="pmc">8769545</ArticleId><ArticleId IdType="doi">10.1126/sciadv.abk2485</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivannikov MV, Van Remmen H (2015) Sod1 gene ablation in adult mice leads to physiological changes at the neuromuscular junction similar to changes that occur in old wild-type mice. Free Radic Biol Med 84:254&#x2013;262</Citation><ArticleIdList><ArticleId IdType="pubmed">25841780</ArticleId><ArticleId IdType="pmc">4762177</ArticleId><ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.03.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, Ezzi SA, Julien JP (2007) Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 104(7):2495&#x2013;2500</Citation><ArticleIdList><ArticleId IdType="pubmed">17277077</ArticleId><ArticleId IdType="pmc">1790867</ArticleId><ArticleId IdType="doi">10.1073/pnas.0606201104</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R, Robertson J, Vande Velde C, Horne P, Ruth DM, Griffin J, Cleveland DW, Cashman NR, Chakrabartty A (2007) An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS. Nat Med 13(6):754&#x2013;759</Citation><ArticleIdList><ArticleId IdType="pubmed">17486090</ArticleId><ArticleId IdType="doi">10.1038/nm1559</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu HN, Tjostheim S, Dasilva K, Taylor D, Zhao B, Rakhit R, Brown M, Chakrabartty A, McLaurin J, Robertson J (2012) Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis. J Neurosci 32(26):8791&#x2013;8799</Citation><ArticleIdList><ArticleId IdType="pubmed">22745481</ArticleId><ArticleId IdType="pmc">6622344</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.5053-11.2012</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier M, Welt T, Wirth F, Montrasio F, Preisig D, McAfoose J, Vieira FG, Kulic L, Spani C, Stehle T et al (2018) A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis. Sci Transl Med 10(470):eaah3924</Citation></Reference><Reference><Citation>Hill MD, Goyal M, Menon BK, Nogueira RG, McTaggart RA, Demchuk AM, Poppe AY, Buck BH, Field TS, Dowlatshahi D et al (2020) Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet 395(10227):878&#x2013;887</Citation><ArticleIdList><ArticleId IdType="pubmed">32087818</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(20)30258-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M, Valentine JS (2009) Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS. Antioxid Redox Signal 11(7):1603&#x2013;1614</Citation><ArticleIdList><ArticleId IdType="pubmed">19271992</ArticleId><ArticleId IdType="pmc">2842589</ArticleId><ArticleId IdType="doi">10.1089/ars.2009.2536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Guan T, Li C, Shang H, Cui L, Li XM, Kong J (2012) SOD1 aggregation in astrocytes following ischemia/reperfusion injury: a role of NO-mediated S-nitrosylation of protein disulfide isomerase (PDI). J Neuroinflammation 9:237</Citation><ArticleIdList><ArticleId IdType="pubmed">23061969</ArticleId><ArticleId IdType="pmc">3526400</ArticleId><ArticleId IdType="doi">10.1186/1742-2094-9-237</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman HJ, Fukuto JM, Torres M (2004) Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am J Physiol Cell Physiol 287(2):C246-256</Citation><ArticleIdList><ArticleId IdType="pubmed">15238356</ArticleId><ArticleId IdType="doi">10.1152/ajpcell.00516.2003</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, Kim K, Rhee SG (2003) Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300(5619):653&#x2013;656</Citation><ArticleIdList><ArticleId IdType="pubmed">12714748</ArticleId><ArticleId IdType="doi">10.1126/science.1080273</ArticleId></ArticleIdList></Reference><Reference><Citation>Claiborne A, Yeh JI, Mallett TC, Luba J, Crane EJ 3rd, Charrier V, Parsonage D (1999) Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry 38(47):15407&#x2013;15416</Citation><ArticleIdList><ArticleId IdType="pubmed">10569923</ArticleId><ArticleId IdType="doi">10.1021/bi992025k</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida K, Kawakishi S (1994) Identification of oxidized histidine generated at the active site of Cu, Zn-superoxide dismutase exposed to H<sub>2</sub>O<sub>2</sub>. Selective generation of 2-oxo-histidine at the histidine 118. J Biol Chem 269(4):2405&#x2013;2410</Citation><ArticleIdList><ArticleId IdType="pubmed">8300566</ArticleId><ArticleId IdType="doi">10.1016/S0021-9258(17)41960-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurahashi T, Miyazaki A, Suwan S, Isobe M (2001) Extensive investigations on oxidized amino acid residues in H(2)O(2)-treated Cu, Zn-SOd protein with LC-ESI-Q-TOF-MS, MS/MS for the determination of the copper-binding site. J Am Chem Soc 123(38):9268&#x2013;9278</Citation><ArticleIdList><ArticleId IdType="pubmed">11562208</ArticleId><ArticleId IdType="doi">10.1021/ja015953r</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, Reaume AG, Scott RW, Cleveland DW (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281(5384):1851&#x2013;1854</Citation><ArticleIdList><ArticleId IdType="pubmed">9743498</ArticleId><ArticleId IdType="doi">10.1126/science.281.5384.1851</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y, Fu R, Deng HX, Siddique T, O&#x2019;Halloran TV (2006) Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice. Proc Natl Acad Sci USA 103(18):7148&#x2013;7153</Citation><ArticleIdList><ArticleId IdType="pubmed">16636274</ArticleId><ArticleId IdType="pmc">1447524</ArticleId><ArticleId IdType="doi">10.1073/pnas.0602048103</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A, Hayward LJ (2003) Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction. J Biol Chem 278(8):5984&#x2013;5992</Citation><ArticleIdList><ArticleId IdType="pubmed">12458194</ArticleId><ArticleId IdType="doi">10.1074/jbc.M210419200</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A, Liba A, Sohn SH, Seetharaman SV, Bilsel O, Matthews CR, Hart PJ, Valentine JS, Hayward LJ (2009) Metal deficiency increases aberrant hydrophobicity of mutant superoxide dismutases that cause amyotrophic lateral sclerosis. J Biol Chem 284(40):27746&#x2013;27758</Citation><ArticleIdList><ArticleId IdType="pubmed">19651777</ArticleId><ArticleId IdType="pmc">2785702</ArticleId><ArticleId IdType="doi">10.1074/jbc.M109.043729</ArticleId></ArticleIdList></Reference><Reference><Citation>Okado-Matsumoto A, Fridovich I (2002) Amyotrophic lateral sclerosis: a proposed mechanism. Proc Natl Acad Sci USA 99(13):9010&#x2013;9014</Citation><ArticleIdList><ArticleId IdType="pubmed">12060716</ArticleId><ArticleId IdType="pmc">124414</ArticleId><ArticleId IdType="doi">10.1073/pnas.132260399</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y, O&#x2019;Halloran TV (2006) Posttranslational modifications in Cu, Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis. Antioxid Redox Signal 8(5&#x2013;6):847&#x2013;867</Citation><ArticleIdList><ArticleId IdType="pubmed">16771675</ArticleId><ArticleId IdType="doi">10.1089/ars.2006.8.847</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Andersen PM, Marklund SL, Brannstrom T (2011) Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol 121(5):623&#x2013;634</Citation><ArticleIdList><ArticleId IdType="pubmed">21287393</ArticleId><ArticleId IdType="pmc">3085063</ArticleId><ArticleId IdType="doi">10.1007/s00401-011-0805-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Valdmanis PN, Dion P, Rouleau GA (2007) Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis? Ann Neurol 62(6):553&#x2013;559</Citation><ArticleIdList><ArticleId IdType="pubmed">18074357</ArticleId><ArticleId IdType="doi">10.1002/ana.21319</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunton-Stasyshyn RK, Saccon RA, Fratta P, Fisher EM (2015) SOD1 function and its implications for amyotrophic lateral sclerosis pathology: new and renascent themes. Neuroscientist 21(5):519&#x2013;529</Citation><ArticleIdList><ArticleId IdType="pubmed">25492944</ArticleId><ArticleId IdType="doi">10.1177/1073858414561795</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>